Allmed Medical Products Co.,Ltd (SHE:002950)

SHE:002950 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	663.25	585.16	397.04	522.2	678.46	1,302
Short-Term Investments	-	-	2.14	-	-	200
Trading Asset Securities	202.37	83.15	96.82	264.63	8.14	35.63
Cash & Short-Term Investments	865.62	668.32	496	786.84	686.6	1,538
Cash Growth	24.61%	34.74%	-36.96%	14.60%	-55.35%	531.34%
Accounts Receivable	443.87	482.75	391.25	521.56	532.46	295.55
Other Receivables	69.85	72.76	68.01	47.38	56.58	51.75
Receivables	513.72	555.51	459.26	568.94	589.04	347.3
Inventory	716.38	615.27	707.21	877.33	846.63	707.28
Other Current Assets	101.09	88.72	117.08	165.85	120.83	243.85
Total Current Assets	2,197	1,928	1,780	2,399	2,243	2,836
Property, Plant & Equipment	1,875	1,829	1,988	2,019	1,603	1,259
Long-Term Investments	849.4	898.22	905.33	824.79	758.68	403.24
Goodwill	95.3	95.3	98.09	98.09	25.99	-
Other Intangible Assets	222.69	182.78	202.66	213.58	234.75	219.53
Long-Term Accounts Receivable	-	-	-	-	17.05	18.76
Long-Term Deferred Tax Assets	44.1	49.14	56.19	48.88	64	44.14
Long-Term Deferred Charges	9.51	6.76	7.08	4.74	1.14	1.26
Other Long-Term Assets	60.51	69.54	46.95	139.79	57.01	68.85
Total Assets	5,353	5,059	5,084	5,748	5,005	4,856
Accounts Payable	388.03	360.87	326.1	897.32	253.86	143.87
Accrued Expenses	88.42	90.01	76.39	84.96	79.82	73.7
Short-Term Debt	465.03	494.31	749.57	792.09	1,060	1,086
Current Portion of Long-Term Debt	-	69.11	54.2	27.15	99.09	-
Current Portion of Leases	3.8	7.68	6.36	2.1	2.27	-
Current Income Taxes Payable	79.59	24.54	6.29	4.93	35.28	85.78
Current Unearned Revenue	26.27	13.02	64.84	129.32	7.8	52.48
Other Current Liabilities	45.12	48.2	41.7	129.06	100.91	23.44
Total Current Liabilities	1,096	1,108	1,325	2,067	1,639	1,465
Long-Term Debt	23.45	89.17	146.32	111.41	127.61	100
Long-Term Leases	0.77	0.43	4.61	5.37	0.6	-
Long-Term Unearned Revenue	265.3	197.51	191.94	189.68	292.17	220.45
Long-Term Deferred Tax Liabilities	218.95	216.04	199.71	243.16	193.82	147.28
Other Long-Term Liabilities	-	-	5.32	-	-	-
Total Liabilities	1,605	1,611	1,873	2,617	2,253	1,933
Common Stock	633.27	633.27	633.27	633.27	633.27	633.27
Additional Paid-In Capital	580.21	580.21	565.77	565.77	564.49	572.56
Retained Earnings	2,624	2,312	1,960	1,888	1,619	1,745
Treasury Stock	-115.9	-97.89	-	-	-	-
Comprehensive Income & Other	9.61	8.96	28.1	14.32	-63.63	-40.15
Total Common Equity	3,731	3,437	3,187	3,101	2,753	2,911
Minority Interest	17.59	11.51	23.73	29.91	-0.91	12.41
Shareholders' Equity	3,749	3,448	3,211	3,131	2,752	2,923
Total Liabilities & Equity	5,353	5,059	5,084	5,748	5,005	4,856
Total Debt	493.05	660.7	961.06	938.13	1,289	1,186
Net Cash (Debt)	372.57	7.62	-465.06	-151.29	-602.53	351.86
Net Cash Per Share	0.59	0.01	-0.73	-0.24	-0.95	0.56
Filing Date Shares Outstanding	618.76	618.76	621.92	633.27	633.27	633.27
Total Common Shares Outstanding	618.76	618.76	633.27	633.27	633.27	633.27
Working Capital	1,101	820.08	454.08	332.03	604.51	1,371
Book Value Per Share	6.03	5.55	5.03	4.90	4.35	4.60
Tangible Book Value	3,413	3,158	2,886	2,789	2,492	2,691
Tangible Book Value Per Share	5.52	5.10	4.56	4.40	3.94	4.25
Buildings	-	1,197	1,220	1,044	989.99	814.48
Machinery	-	1,879	2,044	1,679	1,534	1,120
Construction In Progress	-	27	18.35	400.62	38.24	72.24

Source: S&P Global Market Intelligence. Standard template. Financial Sources.